The Stress and Neuromodulation Lab (SNL) is a research group at Emory University directed by Dr. Sanne van Rooij.
Our research uses neuroimaging, neuromodulation and psychophysiology to gain deeper insights into the mechanisms of resilience and recovery from traumatic stress. Our goal is to identify neurobiological predictors and mechanistic targets to advance the development of innovative therapeutics to promote resilience and mental well-being in the face of adversity.
Based on more than a decade of neuroimaging research, we developed a personalized treatment to directly modulate neurocircuits associated with post-traumatic stress disorder (PTSD). In a clinical trial, we determine the effects of Transcranial Magnetic Stimulation (TMS) on PTSD symptoms and biomarkers using a neuroimaging-guided TMS target (learn more about the study). Results of the trial are expected in 2025.
Learn more about TMS for PTSD
The goal of the TMS for PTSD Study is to significantly contribute to the advancement of new treatment approaches for PTSD and better understand the mechanisms of TMS by:
- Examining the effect of TMS on PTSD neuroimaging and psychophysiological biomarkers.
- Specifying the exact location for the TMS treatment by using pre-treatment MRI scans.